Several of the identified antigens are currently discussed as biomarkers including HSP1, MAZ, and RPS2 that are up-regulated in colorectal cancer, acute myeloid leukaemia, and astrocytoma, respectively [24-26]. This evidence concerns the gene SYPL1 and astrocytoma (excluding glioblastoma).